- Half Year 2023 Genfit SA Earnings Call TranscriptSep 20, 2023$3.72 (+4.49%)Earnings
- Genfit SA and Ipsen SA Announce Positive Results from Phase III ELATIVE® Trial of Elafibranor in Patients with Primary Biliary Cholangitis Call TranscriptJun 30, 2023
- Full Year 2022 Genfit SA Earnings Call TranscriptApr 14, 2023$4 (-1.48%)Earnings
- Genfit SA to Acquire Clinical-Stage Biopharmaceutical Company Versantis AG Call TranscriptSep 19, 2022
- Full Year 2022 Genfit SA Earnings Call TranscriptApr 08, 2022$3.95 (+0.77%)Earnings
- Genfit SA Corporate Call TranscriptDec 17, 2021
- Half Year 2021 Genfit SA Earnings Call TranscriptSep 29, 2021$3.77 (-1.05%)Earnings
- Genfit SA Updates On Pipeline TranscriptMay 11, 2021
- Full Year 2020 Genfit SA Earnings Presentation TranscriptApr 01, 2021
- Half Year 2020 Genfit SA Earnings Call (English) TranscriptSep 30, 2020$5.27 (-3.30%)Earnings
- Q4 2019 Genfit SA Earnings Call TranscriptApr 09, 2020$16.19 (-1.88%)Earnings
Genfit SA Updates On Pipeline Transcript
Greetings, and welcome to Genfit corporate pipeline update conference call. (Operator Instructions) As a reminder, this conference is being recorded.
I would now like to turn the conference over to your host, Stefanie Magner, Chief Compliance Officer. Please go ahead.
Thank you. Good afternoon, everyone, and thank you for joining us for this pipeline and R&D update. We just issued a press release providing details about our pipeline as well as our R&D strategy. This press release can be accessed on our website at ir.genfit.com.
During our call, we will be making forward-looking statements as defined under the U.S. Private Securities Litigation Reform Act of 1995 with respect to Genfit, our expected future performance, business prospects, corporate strategies, events and plans, including our R&D and clinical development programs and financial guidance. These forward-looking statements are based on our management's current assumptions and
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)